Proteomic patterns according to ejection fraction: an EMPEROR-programme analysis.

IF 10.3 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
João Pedro Ferreira, Francesco Fioretti, Mikhail Sumin, Stefan D Anker, Gerasimos Filippatos, Manuel Monroy Kuhn, Marina Panova-Noeva, Jürgen Prochaska, Maral Saadati, Britta Stolze, Cordula Zeller, Faiez Zannad, Javed Butler
{"title":"Proteomic patterns according to ejection fraction: an EMPEROR-programme analysis.","authors":"João Pedro Ferreira, Francesco Fioretti, Mikhail Sumin, Stefan D Anker, Gerasimos Filippatos, Manuel Monroy Kuhn, Marina Panova-Noeva, Jürgen Prochaska, Maral Saadati, Britta Stolze, Cordula Zeller, Faiez Zannad, Javed Butler","doi":"10.1093/ejhf/xuag013","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>Left ventricular ejection fraction (LVEF) has been incorporated as an inclusion criterion in HF trials. Patient's characteristics, event risk, and treatment response vary according to LVEF. A better understanding of the biological processes across LVEF is warranted. To study proteomic biomarker expression across LVEF using data from the EMPEROR-Programme.</p><p><strong>Methods: </strong>Two thousand two hundred and fifty-four patients who had proteomic measurements available using 1134 proteins overlapping between the Explore 1536 and 3072 Olink® platforms were included. Main analyses were performed within the EMPEROR-Preserved dataset due to differences in entry criteria between EMPEROR-Preserved and EMPEROR-Reduced with higher entry N-terminal pro B-type natriuretic peptide (NT-proBNP) levels that varied by LVEF cut-offs in the latter. Protein concentrations were compared using ordinal logistic regression across LVEF categories: 41%-49%, 50%-59%, and ≥60%. The resulting β-coefficient indicates the change in the log-odds for the outcome of being in a lower LVEF category for every NPX unit in log2 scale. Analyses were adjusted for covariates and a false-discovery-rate (FDR) correction was applied.</p><p><strong>Results: </strong>A total of 297 proteins exhibited a trend of expression across LVEF categories in EMPEROR-Preserved after adjustment for potential confounders and correction for test multiplicity. Of these, the top 10 proteins were: NT-pro BNP (β = 0.18, 95% CI 0.09-0.27), Wnt inhibitory factor-1 (β = 0.40, 95% CI 0.19-0.61), sialomucin core protein 24 (β = 0.48, 95% CI 0.22-0.74), phospholipid transfer protein (β = 0.38, 95% CI 0.17-0.59), natriuretic peptides B (β = 0.13, 95% CI 0.06-0.20), intercellular adhesion molecule 5 (β = 0.31, 95% CI 0.14-0.49), neural cell adhesion molecule 2 (β = 0.45, 95% CI 0.19-0.70), neural cell adhesion molecule L1-like protein (β = 0.45, 95% CI 0.19-0.71), interactor protein for cytohesin exchange factors 1 (β = 0.12, 95% CI 0.05-0.19), and 3-ketoacyl-CoA thiolase, peroxisomal (β = 0.17, 95% CI 0.07-0.26). The correlation between these proteins and LVEF was generally weak (Rho ≤0.2).</p><p><strong>Conclusions: </strong>Within EMPEROR-Preserved, the top differentially expressed circulating proteins suggest that pathways related to natriuretic peptides, cell-adhesion, and clonal haematopoiesis are overexpressed at mildly-reduced ejection fraction, but none of the proteins passed the 5%FDR cut-off, and the correlation between circulating proteins and LVEF was weak. These findings suggest that circulating proteins may not be a good discriminant of ejection fraction.</p>","PeriodicalId":164,"journal":{"name":"European Journal of Heart Failure","volume":" ","pages":"425-432"},"PeriodicalIF":10.3000,"publicationDate":"2026-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Heart Failure","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ejhf/xuag013","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: Left ventricular ejection fraction (LVEF) has been incorporated as an inclusion criterion in HF trials. Patient's characteristics, event risk, and treatment response vary according to LVEF. A better understanding of the biological processes across LVEF is warranted. To study proteomic biomarker expression across LVEF using data from the EMPEROR-Programme.

Methods: Two thousand two hundred and fifty-four patients who had proteomic measurements available using 1134 proteins overlapping between the Explore 1536 and 3072 Olink® platforms were included. Main analyses were performed within the EMPEROR-Preserved dataset due to differences in entry criteria between EMPEROR-Preserved and EMPEROR-Reduced with higher entry N-terminal pro B-type natriuretic peptide (NT-proBNP) levels that varied by LVEF cut-offs in the latter. Protein concentrations were compared using ordinal logistic regression across LVEF categories: 41%-49%, 50%-59%, and ≥60%. The resulting β-coefficient indicates the change in the log-odds for the outcome of being in a lower LVEF category for every NPX unit in log2 scale. Analyses were adjusted for covariates and a false-discovery-rate (FDR) correction was applied.

Results: A total of 297 proteins exhibited a trend of expression across LVEF categories in EMPEROR-Preserved after adjustment for potential confounders and correction for test multiplicity. Of these, the top 10 proteins were: NT-pro BNP (β = 0.18, 95% CI 0.09-0.27), Wnt inhibitory factor-1 (β = 0.40, 95% CI 0.19-0.61), sialomucin core protein 24 (β = 0.48, 95% CI 0.22-0.74), phospholipid transfer protein (β = 0.38, 95% CI 0.17-0.59), natriuretic peptides B (β = 0.13, 95% CI 0.06-0.20), intercellular adhesion molecule 5 (β = 0.31, 95% CI 0.14-0.49), neural cell adhesion molecule 2 (β = 0.45, 95% CI 0.19-0.70), neural cell adhesion molecule L1-like protein (β = 0.45, 95% CI 0.19-0.71), interactor protein for cytohesin exchange factors 1 (β = 0.12, 95% CI 0.05-0.19), and 3-ketoacyl-CoA thiolase, peroxisomal (β = 0.17, 95% CI 0.07-0.26). The correlation between these proteins and LVEF was generally weak (Rho ≤0.2).

Conclusions: Within EMPEROR-Preserved, the top differentially expressed circulating proteins suggest that pathways related to natriuretic peptides, cell-adhesion, and clonal haematopoiesis are overexpressed at mildly-reduced ejection fraction, but none of the proteins passed the 5%FDR cut-off, and the correlation between circulating proteins and LVEF was weak. These findings suggest that circulating proteins may not be a good discriminant of ejection fraction.

蛋白质组学模式根据射血分数:一个皇帝程序分析。
目的:左心室射血分数(LVEF)已被纳入心衰试验的纳入标准。患者特征、事件风险和治疗反应因LVEF而异。有必要更好地了解LVEF的生物学过程。利用emperor - program的数据研究LVEF中蛋白质组学生物标志物的表达。方法:使用Explore 1536和3072 Olink®平台之间重叠的1134种蛋白质进行蛋白质组学测量的2454例患者被纳入研究。主要分析是在EMPEROR-Preserved数据集中进行的,因为EMPEROR-Preserved和EMPEROR-Reduced的输入标准不同,输入n端前b型利钠肽(NT-proBNP)水平较高,后者的LVEF截止值不同。使用有序逻辑回归比较LVEF类别的蛋白质浓度:41%-49%,50%-59%和≥60%。所得的β-系数表示在log2尺度下,每个NPX单位处于较低LVEF类别的结果的对数赔率的变化。对分析进行协变量调整,并应用错误发现率(FDR)校正。结果:在调整潜在混杂因素和校正测试多重性后,共有297个蛋白在EMPEROR-Preserved中表现出跨LVEF类别的表达趋势。其中,排名前十的蛋白质是:NT-pro BNP (β = 0.18, 95% CI 0.9 -0.27)、Wnt抑制因子-1 (β = 0.40, 95% CI 0.19-0.61)、唾液蛋白核心蛋白24 (β = 0.48, 95% CI 0.22-0.74)、磷脂转移蛋白(β = 0.38, 95% CI 0.17-0.59)、利钠肽B (β = 0.13, 95% CI 0.06-0.20)、细胞间粘附分子5 (β = 0.31, 95% CI 0.14-0.49)、神经细胞粘附分子2 (β = 0.45, 95% CI 0.19-0.70)、神经细胞粘附分子1样蛋白(β = 0.45, 95% CI 0.19-0.71)、细胞染色素交换因子1相互作用蛋白(β = 0.12, 95% CI 0.05-0.19)和3-酮酰基辅酶a硫酶,过氧化物酶体(β = 0.17, 95% CI 0.07-0.26)。这些蛋白与LVEF的相关性一般较弱(Rho≤0.2)。结论:在emperr - preserved中,顶端差异表达的循环蛋白表明,与利钠肽、细胞粘附和克隆造血相关的途径在射血分数轻度降低时过表达,但没有一个蛋白通过5%FDR的临界值,循环蛋白与LVEF之间的相关性较弱。这些发现表明,循环蛋白可能不是射血分数的良好判别。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
European Journal of Heart Failure
European Journal of Heart Failure 医学-心血管系统
CiteScore
27.30
自引率
11.50%
发文量
365
审稿时长
1 months
期刊介绍: European Journal of Heart Failure is an international journal dedicated to advancing knowledge in the field of heart failure management. The journal publishes reviews and editorials aimed at improving understanding, prevention, investigation, and treatment of heart failure. It covers various disciplines such as molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, clinical sciences, social sciences, and population sciences. The journal welcomes submissions of manuscripts on basic, clinical, and population sciences, as well as original contributions on nursing, care of the elderly, primary care, health economics, and other related specialist fields. It is published monthly and has a readership that includes cardiologists, emergency room physicians, intensivists, internists, general physicians, cardiac nurses, diabetologists, epidemiologists, basic scientists focusing on cardiovascular research, and those working in rehabilitation. The journal is abstracted and indexed in various databases such as Academic Search, Embase, MEDLINE/PubMed, and Science Citation Index.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书